-
Je něco špatně v tomto záznamu ?
Age of obesity onset in MC4R mutation carriers
D. Stanikova, M. Surova, M. Buzga, M. Skopkova, L. Ticha, M. Petrasova, M. Huckova, D. Gabcova-Balaziova, L. Valentova, M. Mokan, I. Zavacka, J. Stanik, I. Klimes, D. Gasperikova,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dítě MeSH
- dospělí MeSH
- fenotyp MeSH
- genetická predispozice k nemoci MeSH
- genetické asociační studie MeSH
- heterozygot MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutace * MeSH
- mutační analýza DNA MeSH
- obezita dětí a dospívajících diagnóza epidemiologie genetika MeSH
- předškolní dítě MeSH
- receptor melanokortinový typ 4 genetika MeSH
- rizikové faktory MeSH
- studie případů a kontrol MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Slovenská republika MeSH
OBJECTIVES: The mutations in gene for the melanocortin-4 receptor (MC4R) are the most common etiology factors of monogenic obesity development. Recently, it has been shown that current life style has a significant impact on the phenotype of MC4R mutation carriers - increases the penetrance of the mutations. We aimed to study the impact of the current age on the time of obesity onset among MC4R mutation carriers. METHODS: DNA analysis of the MC4R gene was performed in 268 unrelated Slovak and Moravian obese children and adolescents 18 years and 28 blood relatives >18 years of the probands with a mutation. RESULTS: Three different previously described heterozygous loss of function MC4R mutations (p.Ser19Alafs*34, p.Ser127Leu, and p.Gly181Asp) were found in 3 <18 years probands, 3 adult probands, and 6 adult obese/overweight family relatives. The age of obesity onset in mutation carriers was 1 year in all probands in the children group and 1-35 years (median 11 years) in adults. The age of the obesity onset significantly correlated (R=0.809, p=0.028) with the current age in all of the MC4R mutation carriers. CONCLUSIONS: The age of obesity onset in the present child generation of MC4R mutation carriers is decreasing compared to the age of onset in their parents' generation. This is in agreement with similarly increasing penetrance of obesity in MC4R mutation carriers and it points out to escalation of obesogenic potential of environment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20014767
- 003
- CZ-PrNML
- 005
- 20200929121144.0
- 007
- ta
- 008
- 200922s2015 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4149/endo_2015_03_137 $2 doi
- 035 __
- $a (PubMed)26238496
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Stanikova, D
- 245 10
- $a Age of obesity onset in MC4R mutation carriers / $c D. Stanikova, M. Surova, M. Buzga, M. Skopkova, L. Ticha, M. Petrasova, M. Huckova, D. Gabcova-Balaziova, L. Valentova, M. Mokan, I. Zavacka, J. Stanik, I. Klimes, D. Gasperikova,
- 520 9_
- $a OBJECTIVES: The mutations in gene for the melanocortin-4 receptor (MC4R) are the most common etiology factors of monogenic obesity development. Recently, it has been shown that current life style has a significant impact on the phenotype of MC4R mutation carriers - increases the penetrance of the mutations. We aimed to study the impact of the current age on the time of obesity onset among MC4R mutation carriers. METHODS: DNA analysis of the MC4R gene was performed in 268 unrelated Slovak and Moravian obese children and adolescents 18 years and 28 blood relatives >18 years of the probands with a mutation. RESULTS: Three different previously described heterozygous loss of function MC4R mutations (p.Ser19Alafs*34, p.Ser127Leu, and p.Gly181Asp) were found in 3 <18 years probands, 3 adult probands, and 6 adult obese/overweight family relatives. The age of obesity onset in mutation carriers was 1 year in all probands in the children group and 1-35 years (median 11 years) in adults. The age of the obesity onset significantly correlated (R=0.809, p=0.028) with the current age in all of the MC4R mutation carriers. CONCLUSIONS: The age of obesity onset in the present child generation of MC4R mutation carriers is decreasing compared to the age of onset in their parents' generation. This is in agreement with similarly increasing penetrance of obesity in MC4R mutation carriers and it points out to escalation of obesogenic potential of environment.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a obezita dětí a dospívajících $x diagnóza $x epidemiologie $x genetika $7 D063766
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a receptor melanokortinový typ 4 $x genetika $7 D044105
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 651 _2
- $a Slovenská republika $x epidemiologie $7 D018154
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Surova, M
- 700 1_
- $a Buzga, M
- 700 1_
- $a Skopkova, M
- 700 1_
- $a Ticha, L
- 700 1_
- $a Petrasova, M
- 700 1_
- $a Huckova, M
- 700 1_
- $a Gabcova-Balaziova, D
- 700 1_
- $a Valentova, L
- 700 1_
- $a Mokan, M
- 700 1_
- $a Zavacka, I
- 700 1_
- $a Stanik, J
- 700 1_
- $a Klimes, I
- 700 1_
- $a Gasperikova, D
- 773 0_
- $w MED00001518 $t Endocrine regulations $x 1210-0668 $g Roč. 49, č. 3 (2015), s. 137-140
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26238496 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200922 $b ABA008
- 991 __
- $a 20200929121140 $b ABA008
- 999 __
- $a ok $b bmc $g 1567628 $s 1104927
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 49 $c 3 $d 137-140 $e - $i 1210-0668 $m Endocrine regulations $n Endocr. Regul. $x MED00001518
- LZP __
- $a Pubmed-20200922